Task Force on Medical Cannabis Therapeutic Research
Two public meetings have been set to discus planning for Minnesota’s new medical marijuana program. The first is on July 31 and will be used to familiarize a 16-member Task Force on Medical Cannabis Therapeutic Research with its duties. The other one is an early-August session by the Office of Medical Cannabis to brief potential manufacturers and others about the timetable and program guidelines.
Gov. Mark Dayton on Thursday appointed 16 members to a task force that will study the impact of the state’s new medical marijuana law. The governor’s appointees to the Task Force on Medical Cannabis Therapeutic Research range from law enforcement officials to people who treat substance abuse to potential patients and their parents.